Bupivacaine hydrochloride monohydrate NEW
| Price | $195 | $483 | $692 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-05-07 |
Product Details
| Product Name: Bupivacaine hydrochloride monohydrate | CAS No.: 73360-54-0 |
| Purity: 99.91% | Supply Ability: 10g |
| Release date: 2025/05/07 |
Product Introduction
Bioactivity
| Name | Bupivacaine hydrochloride monohydrate |
| Description | Bupivacaine hydrochloride monohydrate is a potent NMDA receptor inhibitor of sodium, L-calcium, and potassium channels.Bupivacaine hydrochloride monohydrate inhibits SCN5A channels and is commonly used in the study of chronic pain. |
| In vitro | Bupivacaine hydrochloride monohydrate inhibits synaptic transmission mediated by NMDA receptors in the spinal dorsal horn, which is an area closely associated with central sensitization[1]. Bupivacaine hydrochloride monohydrate affects the voltage dependence of channel activation and steady-state inactivation by shifting the half-maximal activation/inactivation membrane potential to a slightly more negative membrane potential.In the inactivated state, the SCN5A channel shows slight sensitivity to Bupivacaine hydrochloride monohydrate (IC50=2.18±0.16 μM)[3]. Bupivacaine hydrochloride monohydrate reversibly inhibits SK2 channels in a dose-dependent manner, with an IC50 of 16.5 μM[2]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Keywords | SodiumChannel | Sodium Channel | PotassiumChannel | Potassium Channel | NMDA receptor | CalciumChannel | Calcium Channel |
| Inhibitors Related | Phenytoin sodium | Procaine | Urethane | L-Ascorbic acid | Valproic Acid | L-Phenylalanine | L-Aspartic aicd sodium | Lidocaine hydrochloride | Ethyl cinnamate | L-Ascorbic acid sodium salt | 2-Nitrobenzoic acid | Chlorzoxazone |
| Related Compound Libraries | Pain-Related Compound Library | Anti-Neurodegenerative Disease Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | EMA Approved Drug Library | Sodium Channel Targeted Library | Drug Repurposing Compound Library | Neuroprotective Compound Library | Inhibitor Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | Ion Channel Targeted Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/1kg |
VIP1Y
|
Hebei Junhua Import and Export Co., LTD
|
2025-03-24 | |
| $0.00/1kg |
VIP4Y
|
Wuhan Biocar Pharmacy CO.,Ltd.
|
2025-02-21 | |
| $9.00/1kg |
VIP1Y
|
Hebei Ganmiao New material Technology Co., LTD
|
2024-06-19 | |
| $30.00/1KG |
Wuhan Ruichi Technology Co., Ltd
|
2024-01-03 | ||
| $35.00/1kg |
Hebei Xinsheng New Material Technology Co., LTD.
|
2023-10-13 | ||
| $30.00/1KG |
Firsky International Trade (Wuhan) Co., Ltd
|
2023-10-08 | ||
| $0.00/1g |
VIP3Y
|
shandong perfect biotechnology co.ltd
|
2023-08-03 | |
| $0.00/1kg |
VIP2Y
|
Hangzhou ICH Biofarm Co., Ltd
|
2023-06-12 | |
| $100.00/1KG |
Weijer International Trade (Hebei) Co., Ltd
|
2023-03-17 | ||
| $30.00/1KG |
Wuhan wingroup Pharmaceutical Co., Ltd
|
2023-01-04 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY